Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)–revised recommendations of the Neuromyelitis Optica Study Group …

S Jarius, O Aktas, I Ayzenberg, J Bellmann-Strobl… - Journal of …, 2023 - Springer
The term 'neuromyelitis optica spectrum disorders'(NMOSD) is used as an umbrella term that
refers to aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica (NMO) …

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease

O Corbali, T Chitnis - Frontiers in Neurology, 2023 - frontiersin.org
Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) is a spectrum of diseases,
including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and …

Serum glial fibrillary acidic protein is a body fluid biomarker: A valuable prognostic for neurological disease–A systematic review

L Heimfarth, FRS Passos, BS Monteiro… - International …, 2022 - Elsevier
Astrocytes are the most abundant cell type in the human central nervous system, and they
play an important role in the regulation of neuronal physiology. In neurological disorders …

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody …

JA Lopez, M Denkova, S Ramanathan… - Clinical & …, 2021 - Wiley Online Library
Autoimmunity plays a significant role in the pathogenesis of demyelination. Multiple
sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD) and myelin …

NMOSD and MOGAD: an evolving disease spectrum

A Uzawa, FC Oertel, M Mori, F Paul… - Nature Reviews …, 2024 - nature.com
Neuromyelitis optica (NMO) spectrum disorder (NMOSD) is a relapsing inflammatory
disease of the CNS, characterized by the presence of serum aquaporin 4 (AQP4) …

Neuromyelitis optica spectrum disorders

F Costello - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
PURPOSE OF REVIEW This article reviews the cardinal clinical features, distinct
immunopathology, current diagnostic criteria, relapse-related risk factors, emerging …

Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review

P Schindler, O Aktas, M Ringelstein… - Expert Review of …, 2023 - Taylor & Francis
Introduction Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, often
debilitating neuroinflammatory disease, whose predominant clinical manifestations are …

Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease

A Dinoto, E Sechi, EP Flanagan, S Ferrari… - Frontiers in …, 2022 - frontiersin.org
The term neuromyelitis optica spectrum disorder (NMOSD) describes a group of clinical-MRI
syndromes characterized by longitudinally extensive transverse myelitis, optic neuritis …

Serum GFAP–reference interval and preanalytical properties in Danish adults

L Tybirk, CVB Hviid, CS Knudsen… - Clinical Chemistry and …, 2022 - degruyter.com
Objectives Glial fibrillary acidic protein (GFAP) is a promising biomarker that could
potentially contribute to diagnosis and prognosis in neurological diseases. The biomarker is …

Biomarkers in autoimmune diseases of the central nervous system

F Zhang, X Gao, J Liu, C Zhang - Frontiers in immunology, 2023 - frontiersin.org
The autoimmune diseases of the central nervous system (CNS) represent individual
heterogeneity with different disease entities. Although clinical and imaging features make it …